|
MechanismPDE4D inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with White Global Pharmaceutical Corp.
0 Patents (Medical) associated with White Global Pharmaceutical Corp.
100 Deals associated with White Global Pharmaceutical Corp.
100 Translational Medicine associated with White Global Pharmaceutical Corp.